BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 21140206)

  • 1. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.
    Gu F; Schumacher FR; Canzian F; Allen NE; Albanes D; Berg CD; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Buring JE; Chabbert-Buffet N; Chanock SJ; Clavel-Chapelon F; Dumeaux V; Gaziano JM; Giovannucci EL; Haiman CA; Hankinson SE; Hayes RB; Henderson BE; Hunter DJ; Hoover RN; Johansson M; Key TJ; Khaw KT; Kolonel LN; Lagiou P; Lee IM; LeMarchand L; Lund E; Ma J; Onland-Moret NC; Overvad K; Rodriguez L; Sacerdote C; Sánchez MJ; Stampfer MJ; Stattin P; Stram DO; Thomas G; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Virtamo J; Weinstein SJ; Willett WC; Yeager M; Zhang SM; Kaaks R; Riboli E; Ziegler RG; Kraft P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2877-87. PubMed ID: 20810604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF gene polymorphisms and breast cancer in African-American and Hispanic women.
    Sarkissyan M; Mishra DK; Wu Y; Shang X; Sarkissyan S; Vadgama JV
    Int J Oncol; 2011 Jun; 38(6):1663-73. PubMed ID: 21455574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical Illness.
    Ahasic AM; Tejera P; Wei Y; Su L; Mantzoros CS; Bajwa EK; Thompson BT; Christiani DC
    Crit Care Med; 2015 Dec; 43(12):2651-9. PubMed ID: 26427594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of
    Doria PLS; Moscovitz T; Tcherniakovsky M; Fernandes CE; Pompei LM; Wajman M; Nimwegen AV; Haimovich S
    Biomed Res Int; 2018; 2018():8704346. PubMed ID: 30643822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of IGFBP3 gene knockout by the CRISPR/Cas9 system on the IGF-1 pathway in murine cells.
    Eom SY; Kim MM
    Arch Gerontol Geriatr; 2024 May; 125():105484. PubMed ID: 38838451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGFBP3 induced by the TGF-β/EGFRvIII transactivation contributes to the malignant phenotype of glioblastoma.
    Zhang X; Wang G; Gong Y; Zhao L; Song P; Zhang H; Zhang Y; Ju H; Wang X; Wang B; Ren H; Zhu X; Dong Y
    iScience; 2023 May; 26(5):106639. PubMed ID: 37192967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of Berberis vulgaris consumption on plasma levels of IGF-1, IGFBPs, PPAR-γ and the expression of angiogenic genes in women with benign breast disease: a randomized controlled clinical trial.
    Pirouzpanah S; Asemani S; Shayanfar A; Baradaran B; Montazeri V
    BMC Complement Altern Med; 2019 Nov; 19(1):324. PubMed ID: 31752829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current smoking is associated with a larger waist circumference and a more androgenic profile in young healthy women from high-risk breast cancer families.
    Ellberg C; Olsson H; Jernström H
    Cancer Causes Control; 2018 Feb; 29(2):243-251. PubMed ID: 29299723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium.
    Ruiz-Narváez EA; Lunetta KL; Hong CC; Haddad S; Yao S; Cheng TD; Bensen JT; Bandera EV; Haiman CA; Troester MA; Ambrosone CB; Rosenberg L; Palmer JR
    NPJ Breast Cancer; 2016; 2():16034-. PubMed ID: 27942580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the insulin-like growth factor-1 system in breast cancer.
    Christopoulos PF; Msaouel P; Koutsilieris M
    Mol Cancer; 2015 Feb; 14():43. PubMed ID: 25743390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls.
    Fidler MJ; Shersher DD; Borgia JA; Bonomi P
    Ther Adv Med Oncol; 2012 Mar; 4(2):51-60. PubMed ID: 22423264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration.
    Chiu CJ; Conley YP; Gorin MB; Gensler G; Lai CQ; Shang F; Taylor A
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9099-107. PubMed ID: 22058336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in IGFBP-3 regulation between young healthy women from BRCAX families and those belonging to BRCA1/2 families.
    Jernström H; Sellberg G; Borg A; Olsson H
    Eur J Cancer Prev; 2006 Jun; 15(3):233-41. PubMed ID: 16679866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
    Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
    Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review.
    Fletcher O; Gibson L; Johnson N; Altmann DR; Holly JM; Ashworth A; Peto J; Silva Idos S
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):2-19. PubMed ID: 15668470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between IGFBP1 expression and cancer risk: A systematic review and meta-analysis.
    Zhang B; Hong CQ; Lin YW; Luo Y; Ding TY; Xu YW; Peng YH; Wu FC
    Heliyon; 2023 Jun; 9(6):e16470. PubMed ID: 37251476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
    Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H
    Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.